With full confidence in China, where Novartis recorded 17 percent growth last year, one of the fastest among all major ...

Novartis expects to increase its annual sales by least 5% per year in the coming years, CEO Vas Narasimhan said in an ...

One of the largest pharmaceutical companies in the world, Novartis AG, has posted strong quarterly results. It comes on the ...

Novartis AG's revenue and core EPS topped analysts' expectations in Q3. Click here to read more on the analysis of NVS stock ...

Profit rose for Swiss pharmaceutical company Novartis AG in the third quarter of the year compared to the same period of the ...

Novartis reports strong Q3 earnings but faces investor concerns over revenue adjustment and pipeline uncertainties. Learn more about NVS stock here.

Novartis raised its 2024 earnings guidance for the third time on Tuesday, buoyed by wider use of its prescription drugs, but ...

In May 2024, Novartis announced new data that confirm the long-term efficacy and safety of remibrutinib, a highly selective ...

TD Cowen analyst Steve Scala maintained a Hold rating on Novartis (NVS – Research Report) today. The company’s shares closed ...

The pharmaceutical giant raised its full-year guidance for the third time this year after higher third-quarter profit and ...

Novartis expects to increase its annual sales by least 5% per year in the coming years, CEO Vas Narasimhan said in an ...

Novartis AG is a Swiss multinational pharmaceutical corporation with its headquarters in Basel, it is one of the largest ...